3/9/2012

The FDA has approved Abbott's FreeStyle InsuLinx Blood Glucose Monitoring System, which aims to improve the way patients manage their diabetes. The technology includes an automated logbook to help users monitor blood glucose levels and insulin doses, among other features.

Full Story:
Endocrine Today

Related Summaries